News

A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce ...
Worldwide, an estimated 40 million people live with HIV. Two-thirds of this group on the African continent. In 2023, more ...
The first human clinical trials testing a new strategy to protect against HIV infections have yielded promising early results ...
Promising early results from the first human clinical trials with new HIV germline-targeting vaccines were reported. These ...
A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus.
To fight off viral and bacterial invaders, immune cells known as lymphocytes generate antibodies that specifically recognize ...
A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to ...
£35 means we can empower more people living with HIV to challenge stigma with our information workshops, videos and broadcasts. These are the recommended tests for routine use in the UK. They test for ...
To address this, CVD prevention plans rely on ... A Chain Reaction: HIV Vaccines Can Lead to Antibodies Against Antibodies Jan. 17, 2025 — Many vaccines work by introducing a protein to the body ...